Chonglou Saponin VII is primarily used in traditional and modern medicine for its anti-cancer properties. It has been studied for its ability to inhibit the growth of various cancer cells, including liver, lung, and breast cancer. The compound works by inducing apoptosis, or programmed cell death, in cancer cells, making it a potential candidate for cancer therapy. Additionally, it exhibits anti-inflammatory effects, which can be beneficial in treating chronic inflammatory diseases. Research also suggests its potential in enhancing the immune response, making it useful in immunomodulatory treatments. Furthermore, it has been explored for its cardioprotective effects, helping to reduce damage to heart tissues under stress. Overall, Chonglou Saponin VII holds promise in multiple therapeutic areas, particularly in oncology and immunology.